• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

    6/4/24 5:50:06 AM ET
    $ALBT
    $ANNX
    $BARK
    $CAPT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALBT alert in real time by email

    Shares of Healthequity Inc (NASDAQ:HQY) rose sharply in today's pre-market trading as the company reported better-than-expected first-quarter financial results.

    The company reported quarterly earnings of 80 cents per share which beat the analyst consensus estimate of 66 cents, according to data from Benzinga Pro. HealthEquity issued strong FY25 earnings guidance and also issued FY25 revenue guidance with its midpoint above expectations.

    Healthequity shares jumped 5.9% to $85.98 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • MicroAlgo Inc (NASDAQ:MLGO) rose 209.5% to $4.83 in today's pre-market trading. WiMi Hologram Cloud and MicroAlgo announced plans to jointly establish a micro-consciousness quantum research center.
    • Core Scientific Inc (NASDAQ:CORZ) shares gained 51.8% to $7.39 in pre-market trading. Core Scientific announced the signing of a series of 12-year contracts with CoreWeave, the AI Hyperscaler.
    • Annexon, Inc. (NASDAQ:ANNX) gained 31.2% to $6.01 in pre-market trading. Annexon will host a conference call and webcast on Tuesday at 8:30 a.m. ET to discuss GBS phase 3 data.
    • Plutonian Acquisition Corp (NASDAQ:PLTN) gained 29.9% to $8.60 in pre-market trading.
    • SunLink Health Systems Inc (NYSE:SSY) shares rose 24.1% to $0.75 in pre-market trading. SunLink Health Systems said its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care & Rehab senior care facility and related real estate in Houston, Mississippi.
    • FibroGen Inc (NASDAQ:FGEN) gained 18.6% to $1.46 in pre-market trading after the company announced announced that the FDA cleared its Investigational New Drug of FG-3165. Also, the company announced a clinical trial supply agreement with Regeneron Pharmaceuticals to evaluate FG-3165 and FG-3175 in combination with LIBTAYO.
    • WiMi Hologram Cloud Inc – ADR (NASDAQ:WIMI) rose 15.1% to $0.99 in pre-market trading. WiMi Hologram Cloud and MicroAlgo announced plans to jointly establish a micro-consciousness quantum research center.
    • Captivision Inc (NASDAQ:CAPT) shares climbed 14.2% to $3.87 in pre-market trading after dipping 28% on Monday.
    • Lexaria Bioscience Corp (NASDAQ:LEXX) shares gained 13.8% to $4.43 in pre-market trading.  

    Losers

    • Lufax Holding Ltd – ADR (NYSE:LU) shares declined 51.1% to $2.14 in pre-market trading.
    • Avalon Globocare Corp (NASDAQ:ALBT) shares declined 26.2% to $0.91 in pre-market trading after surging 317% on Monday.
    • Hywin Holdings Ltd – ADR (NASDAQ:HYW) shares dipped 22.7% to $0.52 in pre-market trading after jumping 91% on Monday.
    • MingZhu Logistics Holdings Ltd (NASDAQ:YGMZ) shares fell 16.5% to $0.39 in pre-market trading. MingZhu Logistics Holdings shares jumped 32% on Monday after the company announced an agreement to acquire Oxylus Global.
    • NewGenIvf Group Ltd (NASDAQ:NIVF) shares fell 13.8% to $1.19 in pre-market trading. On Monday, NewGenIvf signed a non-binding $617.34 million deal for potential reverse merger with pharma company COVIRIX.
    • Microbot Medical Inc. (NASDAQ:MBOT) shares fell 13% to $1.20 in pre-market trading after jumping 38% on Monday.
    • Sequans Communications SA ADR (NYSE:SQNS) shares fell 11.9% to $0.60 in pre-market trading after declining around 10% on Monday.
    • Bark Inc (NYSE:BARK) shares declined 10.7% to $1.25 in pre-market trading after the company reported downbeat financial results for its fourth quarter and issued FY25 revenue guidance below estimates.
    • ICICI Bank Ltd (NYSE:IBN) shares fell 8.7% to $25.85 in pre-market trading after gaining around 6% on Monday.
    • HDFC Bank Ltd (NYSE:HDB) fell 7.8% to $56.47 in pre-market trading after gaining around 6% on Monday.

    Now Read This: Investor Sentiment Improves, But Dow Falls Over 100 Points

    Get the next $ALBT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALBT
    $ANNX
    $BARK
    $CAPT

    CompanyDatePrice TargetRatingAnalyst
    Core Scientific Inc.
    $CORZ
    3/3/2026$23.00Hold → Buy
    Needham
    Microbot Medical Inc.
    $MBOT
    2/10/2026$5.00Buy
    B. Riley Securities
    HealthEquity Inc.
    $HQY
    1/9/2026$89.00Neutral → Sell
    Goldman
    Core Scientific Inc.
    $CORZ
    1/6/2026$23.00Neutral → Buy
    BTIG Research
    Annexon Inc.
    $ANNX
    12/23/2025$16.00Buy
    Chardan Capital Markets
    Core Scientific Inc.
    $CORZ
    12/18/2025$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Sequans Communications S.A.
    $SQNS
    12/10/2025$18.00Buy
    Lake Street
    HealthEquity Inc.
    $HQY
    12/9/2025$118.00Overweight
    Barclays
    More analyst ratings

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal

    Being Published in the Journal of Vascular and Interventional Radiology, a Premier Peer-Reviewed Journal, Speaks to the Quality and Impact of the Study Company Remains Focused on Expanding Evidence-Based Data to Support Broader Commercial Adoption of the LIBERTY System HINGHAM, Mass., March 24, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, which is already garnering medical and industry attention, today announced the publication of an article in the Journal of Vascular and Interventional Radiology (JVIR), titled "In Vivo Evaluation of a Disposable Endovascular Robotic System for Arterial Per

    3/24/26 8:30:00 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    BARK Announces Up To $28 million in Annual Savings Due to Cost Reduction Initiatives and Potential for Approximately $15 million in IEEPA Tariff Refunds

    BARK, Inc. (NYSE:BARK) ("BARK" or the "Company"), a leading dog brand with a mission to make all dogs happy, today provided an update on the Company's recent cost reduction initiatives and the status of potential refunds of tariffs previously paid under the International Emergency Economic Powers Act ("IEEPA"). Cost Reduction Initiatives BARK has completed a series of cost reduction initiatives during the fourth quarter of fiscal year 2026 as part of a broader effort to improve operating efficiency, and drive profitability and free cash flow of the business. The measures are designed to align the Company's cost structure with current business needs. The Company expects these actions to re

    3/23/26 4:05:00 PM ET
    $BARK
    Other Specialty Stores
    Consumer Discretionary

    Core Scientific Expands Strategic Financing Facility to $1 Billion with Additional $500 Million Commitment from J.P. Morgan

    Core Scientific, Inc. (NASDAQ:CORZ) ("Core Scientific" or the "Company"), a leader in digital infrastructure for high-density colocation, today announced that it closed an additional $500 million commitment provided by JPMorgan Chase Bank, N.A. under the accordion feature of the Company's previously announced 364-day credit facility (the "Facility"). This brings total funded commitments under the Facility to $1.0 billion, including the previously announced $500 million commitment from Morgan Stanley. Borrowings under the Facility bear interest at a rate of the Secured Overnight Financing Rate ("SOFR") plus 250 basis points (2.50%). "We are proud to have commitments from Morgan Stanley and

    3/23/26 7:00:00 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Carson William H. bought $45,360 worth of shares (8,000 units at $5.67), increasing direct ownership by 15% to 62,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    3/12/26 4:31:34 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Weiss Eric Stanton bought $101,700 worth of shares (7,000 units at $14.53), increasing direct ownership by 3% to 252,262 units (SEC Form 4)

    4 - Core Scientific, Inc./tx (0001839341) (Issuer)

    3/10/26 4:08:53 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Large owner Asher Daniel bought $62,974 worth of shares (12,300 units at $5.12) (SEC Form 4)

    4 - SEQUANS COMMUNICATIONS (0001383395) (Issuer)

    1/28/26 4:31:28 PM ET
    $SQNS
    Semiconductors
    Technology

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Core Scientific upgraded by Needham with a new price target

    Needham upgraded Core Scientific from Hold to Buy and set a new price target of $23.00

    3/3/26 10:31:14 AM ET
    $CORZ
    Finance: Consumer Services
    Finance

    B. Riley Securities initiated coverage on Microbot Medical with a new price target

    B. Riley Securities initiated coverage of Microbot Medical with a rating of Buy and set a new price target of $5.00

    2/10/26 8:01:31 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    HealthEquity downgraded by Goldman with a new price target

    Goldman downgraded HealthEquity from Neutral to Sell and set a new price target of $89.00

    1/9/26 8:49:40 AM ET
    $HQY
    Real Estate

    $ALBT
    $ANNX
    $BARK
    $CAPT
    SEC Filings

    View All

    Microbot Medical Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Microbot Medical Inc. (0000883975) (Filer)

    3/24/26 8:30:06 AM ET
    $MBOT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 6-K filed by HDFC Bank Limited

    6-K - HDFC BANK LTD (0001144967) (Filer)

    3/24/26 7:08:57 AM ET
    $HDB
    Commercial Banks
    Finance

    BARK Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Bark, Inc. (0001819574) (Filer)

    3/23/26 4:17:09 PM ET
    $BARK
    Other Specialty Stores
    Consumer Discretionary

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Au Hok Man Jefferson

    3 - NewGenIvf Group Ltd (0001981662) (Issuer)

    3/24/26 8:00:41 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    SEC Form 4 filed by Bharucha Kaizad

    4 - HDFC BANK LTD (0001144967) (Issuer)

    3/24/26 7:42:45 AM ET
    $HDB
    Commercial Banks
    Finance

    SEC Form 4 filed by Srinivasan N

    4 - HDFC BANK LTD (0001144967) (Issuer)

    3/24/26 7:35:52 AM ET
    $HDB
    Commercial Banks
    Finance

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Leadership Updates

    Live Leadership Updates

    View All

    NIVF Appoints Award-Winning Web3 Leader Joshua Chu to Spearhead Tokenization Strategy and Formally Engages Evident Capital to Launch Up to USD 30 Million in Tokenized Bonds by Q1, Outlining 2026 Value Catalysts

    BANGKOK, Jan. 21, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (("NewGen" or the "Company, NASDAQ:NIVF), a technology-driven company building a diversified ecosystem across fertility technology, digital assets, and real estate development, today announced the appointment of award-winning Web3 legal and regulatory specialist Joshua Chu as Senior Counsel to lead the Group's tokenization strategy, alongside the formal engagement of Evident Capital, Hong Kong's first fully integrated, SFC-licensed tokenization and alternative assets platform, to support the launch of NIVF's inaugural tokenized bond issuance of up to USD 30 million targeted for completion by the first quarter of 2026. As S

    1/21/26 8:30:00 AM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    BluSky AI Inc. Appoints Riley Cooney as Corporate Development and Strategy Officer

    Salt Lake City Utah, Dec. 09, 2025 (GLOBE NEWSWIRE) -- BluSky AI Inc. (OTCID: BSAI), a leading developer of prefabricated modular AI infrastructure and Neocloud GPU-as-a-Service infrastructure, proudly announces the appointment of Riley Cooney as its Corporate Development and Strategy Officer. Cooney is a well-respected FP&A and strategic finance executive whose experience includes leadership through a $4B IPO in BTC and Hyperscale infrastructure. Riley has advised on AI and HPC data-center strategy, serving global institutional and Wall Street clients over the past two years. During his five years at Core Scientific (NASDAQ:CORZ), Riley helped scale revenue 24× while growing power capaci

    12/9/25 1:37:56 PM ET
    $CORZ
    Finance: Consumer Services
    Finance

    Captivision Announces Plan to Acquire Montana Goldfields Subsidiary Valued at $750 million creating Nasdaq Listed U.S. Mining Company

    MIAMI, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Captivision Inc. ("Captivision" or the "Company") (NASDAQ:CAPT), a pioneering manufacturer and global LED provider, today announced the execution of a letter of intent ("LOI") for the transformative acquisition of Montana Tunnels Mining, Inc. and the Montana Tunnels Mine, ("Montana Tunnels" or "MTMI"), a wholly owned subsidiary and asset of Montana Goldfields, Inc. ("MGLD" or "Montana Goldfields"). Captivision will be repositioned as a diversified gold mining and related services company, renamed Montana Gold Inc. and will begin trading on Nasdaq under the ticker symbol "MGI" upon completion of the acquisition. The Company will continue to evaluate

    12/2/25 8:00:00 AM ET
    $CAPT
    Industrial Machinery/Components
    Miscellaneous

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lufax Holding Ltd

    SC 13D/A - Lufax Holding Ltd (0001816007) (Subject)

    12/9/24 6:12:27 AM ET
    $LU
    Finance: Consumer Services
    Finance

    SEC Form SC 13G filed by NewGenIvf Group Limited

    SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)

    12/5/24 8:23:57 PM ET
    $NIVF
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Annexon Inc.

    SC 13G/A - Annexon, Inc. (0001528115) (Subject)

    11/14/24 7:21:59 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALBT
    $ANNX
    $BARK
    $CAPT
    Financials

    Live finance-specific insights

    View All

    HealthEquity Reports Record Revenue, Earnings and New HSAs From Sales for Fourth Quarter and Year Ended January 31, 2026, Resulting in Raised Fiscal 2027 Outlook

    Highlights of the fiscal year include: Revenue increased 9% to $1.31 billion.Net income increased 123% to $215.2 million, and net income margin increased to 16% from 8% last year.Net income per diluted share rose to $2.46 from $1.09 one year ago, and non-GAAP net income per diluted share increased 28% to $4.00.Adjusted EBITDA increased 20% to $566.0 million, and Adjusted EBITDA margin increased to 43% from 39% last year.Total HSA Assets grew 14% to $36.5 billion.Returned $301.7 million to shareholders through stock repurchases.Further reduced HSA cash repricing risk with a cumulative $2.35 billion 5-year Treasury bond hedge at 3.92%. Highlights of the fourth quarter include: Revenue incre

    3/17/26 4:01:00 PM ET
    $HQY
    Real Estate

    Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results

    SAN FRANCISCO, March 09, 2026 (GLOBE NEWSWIRE) -- Kyntra Bio (NASDAQ:KYNB), formerly FibroGen (NASDAQ:FGEN), will announce fourth quarter and full year 2025 financial results on Monday, March 16 after market close. Kyntra Bio will also conduct a conference call on that day at 5:00 PM Eastern Time with the investment community to further detail the company's corporate and financial performance. Conference Call and Webcast PresentationKyntra Bio management team will host a conference call and webcast presentation to discuss the financial results and provide a business update. A live Q&A session will follow the brief presentation. Interested parties may access a live audio webcast of the con

    3/9/26 7:00:00 AM ET
    $FGEN
    $KYNB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Core Scientific Announces Fourth Quarter Fiscal Year 2025 Results

    Key Highlights New Top-market Site: Announced an agreement to expand into Hunt County, Texas, which is expected to support ~430 MW of gross power capacity, with an approved ERCOT interconnection ramp schedule. Power Expansion at Existing Locations: Increased gross power capacity by ~300 MW across Dalton, Georgia and Pecos, Texas. Continued Execution on CoreWeave Contract: To date, energized ~350 MW of power and remain on track to deliver ~590 MW by early 2027. Core Scientific, Inc. (NASDAQ:CORZ), a leader in digital infrastructure for high-density colocation services, today announced financial results for the fourth quarter of 2025. "We're now past the halfway point on our e

    3/2/26 4:10:00 PM ET
    $CORZ
    Finance: Consumer Services
    Finance